FindTrial
Sign In

Usefulness Of Homoeopathic Medicine In Atopic Dermatitis

Clinical Utility Of Boger Boenninghausens Characteristics And Repertory In The Treatment Of Atopic Dermatitis - AD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/07/026802
Enrollment
30
Registered
2020-07-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: Homoeopathic medicines: Dose and Potency to be selected according to the case Control Intervention1: No comparator agent has been used: Not applicable

Sponsors

Ila Ratna
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) The sample includes patients of age between 5 year to 60 year ,both sexes and all socioeconomic classes will be included for study. 2) Cases which fulfils the diagnostic criteria. 3) Patients who are willing to follow up and ready to consent.

Exclusion criteria

Exclusion criteria: 1)Patient who requires emergency medical treatment. 2)Patients who not fulfilling the diagnostic criteria. 3)Patient not taking medicines as per direction or not co-operating for follow up. 4)Any other disease other than atopic dermatitis.

Design outcomes

Primary

MeasureTime frame
To assess the utility of BBCR in Atopic DermatitisTimepoint: 16 months—

Secondary

MeasureTime frame
To assess the change in Serum IgE levelTimepoint: 18 months—

Countries

India

Contacts

Public ContactIla Ratna

State National Homoeopathic Medical College and Hospital

nayakamit86@gmail.com8318016242

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026